Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein
- 31 August 1999
- journal article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 53 (7), 323-328
- https://doi.org/10.1016/s0753-3322(00)88505-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor alphaThe Journal of Immunology, 2018
- The Concept of Immunological SurveillancePublished by S. Karger AG ,2015
- Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDSProceedings of the National Academy of Sciences of the United States of America, 1998
- A Comparative Analysis of the Interactions of the E6 Proteins from Cutaneous and Genital Papillomaviruses with p53 and E6AP in Correlation to Their Transforming PotentialVirology, 1997
- In VitroAntigene Therapy Targeting HPV-16 E6 and E7 in Cervical CarcinomaGynecologic Oncology, 1997
- Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancerInternational Journal of Cancer, 1996
- The Association of Human Papillomavirus Type 16 E6 and E7 Antibodies with Stage of Cervical CancerGynecologic Oncology, 1996
- Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7Virology, 1991
- Inhibition of Antigen-Induced Lymphocyte Proliferation by Tat Protein from HIV-1Science, 1989
- A dot-immunobinding assay for monoclonal and other antibodiesAnalytical Biochemistry, 1982